| 000 | 01517 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518003952.0 | ||
| 264 | 0 | _c20190109 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1432-2072 | ||
| 024 | 7 |
_a10.1007/s00213-018-5081-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSteffens, M | |
| 245 | 0 | 0 |
_aEffects of ketamine on brain function during response inhibition. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cDec 2018 |
||
| 300 |
_a3559-3571 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aEye Movements _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetamine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhotic Stimulation _xmethods |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSchizophrenia _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aNeumann, C | |
| 700 | 1 | _aKasparbauer, A-M | |
| 700 | 1 | _aBecker, B | |
| 700 | 1 | _aWeber, B | |
| 700 | 1 | _aMehta, M A | |
| 700 | 1 | _aHurlemann, R | |
| 700 | 1 | _aEttinger, U | |
| 773 | 0 |
_tPsychopharmacology _gvol. 235 _gno. 12 _gp. 3559-3571 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-018-5081-7 _zAvailable from publisher's website |
| 999 |
_c28974752 _d28974752 |
||